MYB and breast cancer: Through bioinformatic analysis using the TargetScan algorithm, we identified MYB, a well-characterized oncogene in breast cancer, as a top candidate due to the presence of a highly conserved binding site for miRNA-195-5p in its 3′ untranslated region (3′UTR) (Figure 4(a)).